MedKoo Cat#: 462191 | Name: WF-47-JS03
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

WF-47-JS03 is a potent and selective inhibitor of the RET (REarranged during Transfection) kinase, exhibiting significant anti-tumor activity in preclinical studies. It demonstrates high selectivity, being over 500-fold more selective for RET kinase compared to KDR. In cellular assays, WF-47-JS03 effectively inhibits proliferation of Ba/F3 cells transfected with KIF5B-RET (IC₅₀ = 1.7 nM) and LC-2/ad lung cancer cells expressing CCDC6-RET (IC₅₀ = 5.3 nM).

Chemical Structure

WF-47-JS03
WF-47-JS03
CAS#unknown

Theoretical Analysis

MedKoo Cat#: 462191

Name: WF-47-JS03

CAS#: unknown

Chemical Formula: C30H38N6O2

Exact Mass: 514.3056

Molecular Weight: 514.67

Elemental Analysis: C, 70.01; H, 7.44; N, 16.33; O, 6.22

Price and Availability

Size Price Availability Quantity
5mg USD 650.00 2 Weeks
10mg USD 1,150.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
WF-47-JS03
IUPAC/Chemical Name
3-(3,4-dimethoxyphenyl)-N5-(1,2,2,6,6-pentamethylpiperidin-4-yl)-6-phenylpyrazolo[1,5-a]pyrimidine-5,7-diamine
InChi Key
YRBWLEAMGAGYBK-UHFFFAOYSA-N
InChi Code
InChI=1S/C30H38N6O2/c1-29(2)16-21(17-30(3,4)35(29)5)33-27-25(19-11-9-8-10-12-19)26(31)36-28(34-27)22(18-32-36)20-13-14-23(37-6)24(15-20)38-7/h8-15,18,21H,16-17,31H2,1-7H3,(H,33,34)
SMILES Code
NC1=C(C2=CC=CC=C2)C(NC3CC(C)(C)N(C)C(C)(C)C3)=NC4=C(C5=CC(OC)=C(OC)C=C5)C=NN41
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 514.67 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Mathison CJN, Chianelli D, Rucker PV, Nelson J, Roland J, Huang Z, Yang Y, Jiang J, Xie YF, Epple R, Bursulaya B, Lee C, Gao MY, Shaffer J, Briones S, Sarkisova Y, Galkin A, Li L, Li N, Li C, Hua S, Kasibhatla S, Kinyamu-Akunda J, Kikkawa R, Molteni V, Tellew JE. Efficacy and Tolerability of Pyrazolo[1,5-a]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma. ACS Med Chem Lett. 2020 Feb 12;11(4):558-565. doi: 10.1021/acsmedchemlett.0c00015. PMID: 32292564; PMCID: PMC7153282.